Phlox Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.07M
- Investors
-
6
Phlox Therapeutics General Information
Description
Developer of gene therapeutics intended to alleviate and cure different heart diseases. The company's technology includes gene therapy, an RNA-based therapeutic product and other cardiac therapeutics providing lifelong benefits, enabling patients to reduce the negative effects caused by genetic mutations and to access therapeutic technology that can cure genetic heart diseases.
Contact Information
Website
www.phloxtherapeutics.comCorporate Office
- Gooimeer 2-35
- 1411 DC Naarden
- Netherlands
Corporate Office
- Gooimeer 2-35
- 1411 DC Naarden
- Netherlands
Phlox Therapeutics Timeline
Phlox Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 06-Nov-2024 | $2.07M | Completed | Pre-Clinical Trials | ||
| 2. Seed Round | 18-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 16-May-2022 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Phlox Therapeutics Patents
Phlox Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025064905-A1 | Therapeutic constructs and related methods to treat rbm20-related cardiomyopathy | Inactive | 20-Sep-2023 |
Phlox Therapeutics Signals
Phlox Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ROM Utrecht Region | Impact Investing | Minority | ||
| Innovatiefonds Noord-Holland | Venture Capital | Minority | ||
| Utrecht Health Seed Fund | Venture Capital | Minority | ||
| UvA Ventures Holding | Venture Capital | Minority | ||
| Amsterdam UMC Ventures Holding | Venture Capital | Minority |
Phlox Therapeutics FAQs
-
When was Phlox Therapeutics founded?
Phlox Therapeutics was founded in 2022.
-
Where is Phlox Therapeutics headquartered?
Phlox Therapeutics is headquartered in Naarden, Netherlands.
-
What is the size of Phlox Therapeutics?
Phlox Therapeutics has 7 total employees.
-
What industry is Phlox Therapeutics in?
Phlox Therapeutics’s primary industry is Biotechnology.
-
Is Phlox Therapeutics a private or public company?
Phlox Therapeutics is a Private company.
-
What is Phlox Therapeutics’s current revenue?
The current revenue for Phlox Therapeutics is .
-
How much funding has Phlox Therapeutics raised over time?
Phlox Therapeutics has raised $2.07M.
-
Who are Phlox Therapeutics’s investors?
ROM Utrecht Region, Innovatiefonds Noord-Holland, Utrecht Health Seed Fund, UvA Ventures Holding, and Amsterdam UMC Ventures Holding are 5 of 6 investors who have invested in Phlox Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process